Langar Global HealthTech ETF (LGHT)
10.26
-0.06
(-0.53%)
USD |
NYSEARCA |
Jan 15, 16:00
Price Chart
Key Stats
| Net Expense Ratio | Discount or Premium to NAV | Total Assets Under Management | 30-Day Average Daily Volume |
|---|---|---|---|
| 0.85% | 0.14% | 4.105M | 1489.13 |
| Weighted Average Dividend Yield | Turnover Ratio (Generic) | 1 Year Fund Level Flows | Max Drawdown (Since Inception) |
| 0.35% | 35.00% | 1.961M | Upgrade |
Basic Info
| Investment Strategy | |
| The Fund seeks long-term growth of capital. The fund is an actively-managed ETF that intends to invest a majority of its net assets in US and foreign exchange-listed healthcare technology companies in the US and a number of developed countries around the world which may be of any market capitalization. |
| General | |
| Security Type | Exchange-Traded Fund |
| Equity Style | Multi Cap Growth |
| Broad Asset Class | Sector Equity |
| Broad Category | Equity |
| Global Peer Group | Equity Sector Healthcare |
| Peer Group | Global Health/Biotechnology Funds |
| Global Macro | Equity Industry Sector |
| US Macro | World Sector Equity Funds |
| YCharts Categorization | -- |
| YCharts Benchmark | -- |
| Prospectus Objective | Global Health/Biotechnology Funds |
| Fund Owner Firm Name | Langar |
| Broad Asset Class Benchmark Index | |
| ^MSWNTR | 100.0% |
Performance Versus Peer Group
Annual Total Returns Versus Peers
As of January 16, 2026.
Asset Allocation
As of December 31, 2025.
| Type | % Net |
|---|---|
| Cash | 13.45% |
| Stock | 86.55% |
| Bond | 0.00% |
| Convertible | 0.00% |
| Preferred | 0.00% |
| Other | 0.00% |
Basic Info
| Investment Strategy | |
| The Fund seeks long-term growth of capital. The fund is an actively-managed ETF that intends to invest a majority of its net assets in US and foreign exchange-listed healthcare technology companies in the US and a number of developed countries around the world which may be of any market capitalization. |
| General | |
| Security Type | Exchange-Traded Fund |
| Equity Style | Multi Cap Growth |
| Broad Asset Class | Sector Equity |
| Broad Category | Equity |
| Global Peer Group | Equity Sector Healthcare |
| Peer Group | Global Health/Biotechnology Funds |
| Global Macro | Equity Industry Sector |
| US Macro | World Sector Equity Funds |
| YCharts Categorization | -- |
| YCharts Benchmark | -- |
| Prospectus Objective | Global Health/Biotechnology Funds |
| Fund Owner Firm Name | Langar |
| Broad Asset Class Benchmark Index | |
| ^MSWNTR | 100.0% |